Home > Healthcare > Biotechnology > Bioservices > proteomics market
Get a free sample of Proteomics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Proteomics Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Some of the major market players operating in the proteomics industry are :
These market players are currently undertaking various strategic initiatives such as product launches and approvals to sustain the growing market competition and improve their market share in the global proteomics industry. Additionally, players are also favouring acquisitions and mergers as a part of their strategic roadmap, with an aim of providing a competitive edge by incorporating new technologies in their product and service portfolio, leading to the enhancement of the revenue for companies.
Europe proteomics market is anticipated to cross USD 42 billion by 2032, as a result of the rise in government funding for clinical life sciences research projects.
Consumables component segment will cross USD 83.5 billion by 2032, due to the application scope of kits, strips, and other consumables in biological sample examination.
The market size for proteomics crossed USD 46.5 billion in 2022 and is poised to depict more than 10% CAGR through 2023-2032, given the escalating investment in cancer proteogenomics.
Seer, Inc, Biognosys AG, Creative ProteomicsAgilent Technologies, Inc, Promega Corporation, Thermo Fisher Scientific, Bruker, Bio-Rad Laboratories, Quantum-Si, Inc, PREOMICS GMBH, and Olink are some of the key companies included in the market.